Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Michael Willmann"'
Autor:
Andras Polyak, Heidi Harting, Nina Angrisani, Timo Herrmann, Nina Ehlert, Jessica Meißner, Michael Willmann, Silav Al-Bazaz, Tobias L. Ross, Jens P. Bankstahl, Janin Reifenrath
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-20 (2023)
Abstract Background Implant infections caused by biofilm forming bacteria are a major threat in orthopedic surgery. Delivering antibiotics directly to an implant affected by a bacterial biofilm via superparamagnetic nanoporous silica nanoparticles co
Externí odkaz:
https://doaj.org/article/644e5b3e2b084f3fb3280f401e6dbecb
Autor:
Michael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, Mauro Dacasto, Emir Hadzijusufovic, Olivier Hermine, Irina Sadovnik, Susanne Gamperl, Mathias Schneeweiss-Gleixner, Karoline V. Gleixner, Thomas Böhm, Barbara Peter, Gregor Eisenwort, Richard Moriggl, Zhixiong Li, Mohamad Jawhar, Karl Sotlar, Erika Jensen-Jarolim, Veronika Sexl, Hans-Peter Horny, Stephen J. Galli, Michel Arock, David M. Vail, Matti Kiupel, Peter Valent
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Mast cell neoplasms are one of the most frequently diagnosed malignancies in dogs. The clinical picture, course, and prognosis vary substantially among patients, depending on the anatomic site, grade and stage of the disease. The most frequently invo
Externí odkaz:
https://doaj.org/article/4d0b2c0063b54593ba1b2814f43e664c
Autor:
Katharina Blatt, Ingeborg Menzl, Gregor Eisenwort, Sabine Cerny-Reiterer, Harald Herrmann, Susanne Herndlhofer, Gabriele Stefanzl, Irina Sadovnik, Daniela Berger, Alexandra Keller, Alexander Hauswirth, Gregor Hoermann, Michael Willmann, Thomas Rülicke, Heinz Sill, Wolfgang R. Sperr, Christine Mannhalter, Junia V. Melo, Ulrich Jäger, Veronika Sexl, Peter Valent
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 6, Pp 632-642 (2018)
Leukemic stem cells (LSCs) are an emerging target of curative anti-leukemia therapy. In acute lymphoblastic leukemia (ALL), LSCs frequently express CD34 and often lack CD38. However, little is known about markers and targets expressed in ALL LSCs. We
Externí odkaz:
https://doaj.org/article/1452d10d7e4546a986e7d94a5ac51778
Autor:
Barbara Peter, Karoline V. Gleixner, Sabine Cerny-Reiterer, Harald Herrmann, Viviane Winter, Emir Hadzijusufovic, Veronika Ferenc, Karina Schuch, Irina Mirkina, Hans-Peter Horny, Winfried F. Pickl, Leonhard Müllauer, Michael Willmann, Peter Valent
Publikováno v:
Haematologica, Vol 96, Iss 5 (2011)
Background In advanced systemic mastocytosis the response of neoplastic mast cells to conventional drugs is poor and the prognosis is bad. Current research is, therefore, attempting to identify novel drug targets in neoplastic mast cells. Polo-like k
Externí odkaz:
https://doaj.org/article/266949ddbdba4fd99fe7805468ab1d9b
Autor:
Michael Willmann, Barbara Peter, Katharina Slavnitsch, Daniela Berger, Nadine Witzeneder, Gabriele Stefanzl, Gregor Eisenwort, Daniel Ivanov, Irina Sadovnik, Emir Hadzijusufovic, Georg Greiner, Tina Bernthaler, Gregor Hoermann, Maik Dahlhoff, Thomas Rülicke, Peter Valent
Publikováno v:
Leukemia. 37:1162-1165
Autor:
Daniel Ivanov, Jelena D. Milosevic Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Michael Willmann, Georg Greiner, Katharina Slavnitsch, Emir Hadzijusufovic, Thomas Rülicke, Maik Dahlhoff, Gregor Hoermann, Sigrid Machherndl‐Spandl, Gregor Eisenwort, Michael Fillitz, Thamer Sliwa, Maria‐Theresa Krauth, Peter Bettelheim, Wolfgang R. Sperr, Elisabeth Koller, Michael Pfeilstöcker, Heinz Gisslinger, Felix Keil, Robert Kralovics, Peter Valent
Publikováno v:
American Journal of Hematology. 98:770-783
Autor:
Barbara Peter, Gregor Eisenwort, Irina Sadovnik, Karin Bauer, Michael Willmann, Thomas Rülicke, Daniela Berger, Gabriele Stefanzl, Georg Greiner, Gregor Hoermann, Alexandra Keller, Dominik Wolf, Martin Čulen, Georg E. Winter, Thomas Hoffmann, Ana‐Iris Schiefer, Wolfgang R. Sperr, Johannes Zuber, Jiří Mayer, Peter Valent
Publikováno v:
American Journal of Hematology. 97:1215-1225
Autor:
Erika Jensen-Jarolim, Renate Kunert, Edzard Spillner, Thomas Stockner, Michael Willmann, Yuri Sobanov, Diana Mechtcheriakova, Sarah Meitz, Willibald Steinfellner, Alexander Mader, Miroslawa Matz, Marlene Weichselbaumer, Wei Wang, Judit Fazekas, Josef Singer
Passive immunotherapy with monoclonal antibodies represents a cornerstone of human anticancer therapies, but has not been established in veterinary medicine yet. As the tumor-associated antigen EGFR (ErbB-1) is highly conserved between humans and dog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58318340870bfd8c0a458c923444cd75
https://doi.org/10.1158/1535-7163.c.6536623.v1
https://doi.org/10.1158/1535-7163.c.6536623.v1
Autor:
Erika Jensen-Jarolim, Renate Kunert, Edzard Spillner, Thomas Stockner, Michael Willmann, Yuri Sobanov, Diana Mechtcheriakova, Sarah Meitz, Willibald Steinfellner, Alexander Mader, Miroslawa Matz, Marlene Weichselbaumer, Wei Wang, Judit Fazekas, Josef Singer
PDF - 94K, Supplementary Methods.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::221169b898265f9565c40dd2f931b89b
https://doi.org/10.1158/1535-7163.22500916
https://doi.org/10.1158/1535-7163.22500916
Autor:
Peter Valent, Thomas Rülicke, Matthias Mayerhofer, Wolfgang R. Sperr, Werner Rabitsch, Berthold Streubel, Susanne Herndlhofer, Irina Sadovnik, Sabine Cerny-Reiterer, Michael Willmann, Gregor Hoermann, Harald Herrmann, Katharina Blatt
PDF file - 85K, Supplementary Table S1: Characteristics of patients with MDS Supplementary Table S2: Characteristics of patients with AML Supplementary Table S3: Characteristics of patients with CML, CMML, MPS, AUL, and ALL Supplementary Table S4: Ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbc14d9bd431cb4b2cc6a98ae0c327a
https://doi.org/10.1158/1078-0432.22448301.v1
https://doi.org/10.1158/1078-0432.22448301.v1